MannKind Corporation (MNKD) Financials

MNKD Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 475.2 million 721.4 million
2023-09-30 320.3 million 572.1 million
2023-06-30 313.4 million 573.9 million
2023-03-31 298.1 million 553.5 million

MNKD Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 15.8 million 3.8 million
2023-09-30 -2.7 million 4.6 million
2023-06-30 -14.3 million 5.6 million
2023-03-31 -7.2 million 3.7 million

MNKD Net Income

No data available :(

MNKD Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 295.1 million - 3.9 million
2023-09-30 141.0 million - 4.3 million
2023-06-30 144.3 million - 4.6 million
2023-03-31 166.1 million 225.8 million 4.9 million

MNKD Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 323.9 million
2023-09-30 323.8 million
2023-06-30 265.6 million
2023-03-31 264.0 million

MNKD Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 5.9 million 9.2 million 9.5 million 11.0 million
2023-09-30 11.4 million 10.0 million 10.5 million 13.4 million
2023-06-30 16.9 million 6.5 million 11.9 million 14.0 million
2023-03-31 8.3 million 5.6 million 10.5 million 13.3 million

MNKD Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 58.5 million 18.1 million
2023-09-30 51.3 million 14.3 million
2023-06-30 48.6 million 14.2 million
2023-03-31 40.6 million 16.2 million

MNKD

Price: $4.40

52 week price:
3.17
5.75

Earnings Per Share: -0.04 USD

P/E Ratio: -28.83

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 1.9 million

Ebitda: -28.5 million

Market Capitalization: 1.2 billion

Links: